Delivery Order SPE2DB20D3104-SPE2DB23FV7V5
- Not listed
- This federal contract award, valued at $5,540.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ferumoxytol, a 510 mg/17 ml vial medication, with a completion date of July 13, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies,...
- This federal contract award, valued at $1,080.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a 17 ml medication. The award is a firm fixed-price delivery order with a completion date of July 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,143.06 firm fixed price delivery order is for the supply of Ferumoxytol 510 mg/17 ml vials, a specialty medication. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
- This federal contract award is for the delivery of Ferumoxytol, a 510 mg/17 ml vial, to the Defense Logistics Agency (DLA). The $3,724.60 firm fixed price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $1,282.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of ferumoxytol, a 510 mg/17 ml vial medication, with a completion date of September 25, 2024. The contract is a Delivery Order type with a Firm Fixed Price pricing structure. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, has been awarded...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract has a firm fixed price, with a ceiling value of $8,423.11, and a completion date of October 10, 2024. This contract is not designated as a set-aside. AmerisourceBergen, through its Corporate Office division, has been awarded multiple federal contracts and indefinite delivery contracts...
- The Defense Logistics Agency awarded a delivery order valued at $17,822 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials, with an ultimate completion date of January 27, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- This federal contract award, valued at $2,793.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566602430 - FERUMOXYTOL 510 MG/17 ML VIAL 17ML, with a completion date of December 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- The Defense Logistics Agency awarded a $5,532.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which is not set aside for any specific business category, represents a competitively awarded transaction with an ultimate completion date of January 21, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- This is a $12,418.16 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565664131 - Ferumoxytol 510 mg/17 ml vial with a completion date of September 4, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and is responsible for providing this critical medical product to support federal healthcare programs and military treatment...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV7V5Delivery Order
This federal contract award, valued at $5,540.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vials, a pharmaceutical product used in medical treatment. The contract is a Firm Fixed Price Delivery Order with a completion date of July 17, 2023. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/14/23 |